Shenzhen Dazhou Medical Technology develops biomaterials and 3D-printed medical implants, including orthopedic and dental devices.
Based in Shenzhen, China, and established in 2019, Shenzhen Dazhou Medical Technology develops biomedical materials, 3D-printed orthopedic and dental implants, bioprinting and regenerative medicine products, including the Tanlumbone bimetallic orthopedic implant material. The company was selected for the 2022 Venture50 New Talent List and had applied for or obtained more than 20 national invention patents as of 2024. In May 2020 it closed angel funding, and founder, CEO and chairman Jingzhou Yang graduated from Harvard University.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in